Of executive preferences and societal constraints: The domestic politics of the transatlantic GMO dispute1-Reference-Cited by-同舟云学术

Of executive preferences and societal constraints: The domestic politics of the transatlantic GMO dispute1

Published:2011-10 Issue:4 Volume:18 Page:506-529
ISSN:0969-2290
Container-title:Review of International Political Economy
language:en
Short-container-title:Review of International Political Economy

Author:

Young Alasdair R.

Publisher

Informa UK Limited

Subject

Political Science and International Relations,Economics and Econometrics,Sociology and Political Science

Link

http://www.tandfonline.com/doi/pdf/10.1080/09692290.2010.483885

Reference90 articles.

1. Allee, T. 2003. “‘Legal Incentives and Domestic Rewards: The Selection of Trade Disputes for GATT/WTO Dispute Resolution’”. University of Illinois, 9 October. Unpublished paper

2. Resolving or Exacerbating Disputes? The WTO's New Dispute Resolution System

3. Bananas, Beef, and Biotechnology: Three Contentious U.S.-EU Trade Disputes

4. Amicus Coalition. 2004. “’Information Submitted to the Panel by Non-Parties‘”. European Communities – Measures Affecting the Approval and Marketing of Biotech Products (DS291, DS292, DS293). 27 May. (accessed 7 July 2008)

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Social Concerns and Regulation of Cisgenic Crops in North America;Concepts and Strategies in Plant Sciences;2023

2. New champions of preferential trade? Two-level games in China’s and India’s shifting commercial strategies;Review of International Political Economy;2022-04-27

3. A new delegation design for EU governance: how preference cohesiveness of multiple principals shapes the European Commission’s discretion in trade negotiations;Comparative European Politics;2021-06-24

4. Patents for self‐replicating technologies: Game theoretic analysis of genetically modified seed;The Journal of World Intellectual Property;2020-02-25

5. Transnational pharmacogovernance: emergent patterns in the jazz of pharmaceutical policy convergence;Globalization and Health;2018-08-22